UNITED CAPITAL FINANCIAL ADVISORS, LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 59 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.54 and the average weighting 0.7%.

Quarter-by-quarter ownership
UNITED CAPITAL FINANCIAL ADVISORS, LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$5,000
-37.5%
10,0000.0%0.00%
Q2 2020$8,000
-20.0%
10,0000.0%0.00%
Q1 2020$10,000
-37.5%
10,0000.0%0.00%
Q4 2019$16,000
-11.1%
10,0000.0%0.00%
Q3 2019$18,000
+12.5%
10,0000.0%0.00%
Q2 2019$16,000
-11.1%
10,0000.0%0.00%
Q1 2019$18,000
-5.3%
10,0000.0%0.00%
Q4 2018$19,000
-47.2%
10,0000.0%0.00%
Q3 2018$36,000
+71.4%
10,0000.0%0.00%
Q2 2018$21,00010,0000.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
CVI Holdings, LLC 1,484,714$2,658,0002.52%
ESSEX INVESTMENT MANAGEMENT CO LLC 549,750$984,0000.14%
BARD ASSOCIATES INC 88,184$158,0000.08%
EAM Investors, LLC 160,628$288,0000.07%
Regal Investment Advisors LLC 193,450$346,0000.07%
HighTower Advisors, LLC 5,284,838$9,460,0000.06%
HIGHLAND CAPITAL MANAGEMENT LP 545,000$976,0000.06%
Granite Point Capital Management, L.P. 329,000$589,0000.06%
Kore Private Wealth LLC 104,366$187,0000.04%
Verition Fund Management LLC 498,167$892,0000.04%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders